Scientific papers

2022

Acetaminophen (APAP, Paracetamol) Interferes With the First Trimester Human Fetal Ovary Development in an Ex Vivo Model.

From cohorts to molecules: Adverse impacts of endocrine disrupting mixtures.

2021

The mammalian ovary: Concerns about the evaluation of prenatal environmental exposures.

Follicular fluid and blood levels of persistent organic pollutants and reproductive outcomes among women undergoing assisted reproductive technologies.

The insulin-like growth factor system: A target for endocrine disruptors?

A pragmatic approach to Adverse Outcome Pathways (AOP) development and evaluation.

Six decades of research on human fetal gonadal steroids.

Maternal over-the-counter analgesics use during pregnancy and adverse perinatal outcomes: Cohort study of 151,141 singleton pregnancies.

A putative adverse outcome pathway network for disrupted female pubertal onset to improve testing and regulation of endocrine disrupting chemicals.

Classical toxicity endpoints in female rats are insensitive to the human endocrine disruptors diethylstilbestrol and ketoconazole.

2020

Putative adverse outcome pathways for female reproductive disorders to improve testing and regulation of chemicals.

Testing the twin testosterone transfer hypothesis – intergenerational analysis of 317 dizygotic twins born in Aberdeen, Scotland.

Safeguarding female reproductive health against endocrine disrupting chemicals – the FREIA project.

Dynamics of the transcriptional landscape during human fetal testis and ovary development.

Persistent environmental endocrine-disrupting chemicals in ovarian follicular fluid and in vitro fertilization treatment outcome in women.

Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat.

Single-cell analysis of human ovarian cortex identifies distinct cell populations but no oogonial stem cells.